Federal funding of human embryonic stem cell (hESC) research is hanging by a tenuous thread at the moment. While currently legal, such funding is at the mercy of a legal case making its way through the courts. The latest stop for this case is a review by a 3-judge panel of the DC Circuit Court. […]
Update on embryonic stem cell court case Read More »
Doris Taylor is heading southeast? Texas is holding up a Texas-sized magnet for stem cell super star researchers and it is working. The upper mid-West is reeling from the departure of two stem cell superstars in less than one year and both went South to Texas. First in May 2011, we had the departure of
It’s difficult to dispute that statement, but is email good or bad for science? Scientists are addicted to email. Superficially, it is easy to make the case that email is good for science. Email allows scientists all over the world to rapidly communicate with each other in ways that simply were not possible prior to
Is email bad for science? Read More »
Today after years of following the company Advanced Cell Technology (ACT), I finally bought stock (ACTC) in it. Why? As a stem cell researcher myself working on human ES cells, iPS cells, and many other types of stem cells, I have been following ACT for years, but have never pulled the trigger to buy their stock….until
Why I finally bought stock in Advanced Cell Technology Read More »
What does it take to succeed in research including for science newbies? Here are some key ingredients in my opinion after 22 years in academic science. Passion. One important ingredient that we cannot necessarily change significantly about ourselves, but that I think nonetheless is crucial for success, is a true excitement for science. Sometimes people
While my gel was running: advice for success for science newbies Read More »
This post is focused on the important facts you need to know about stem cells as drugs and stem cell treatments. Many of the folks out there who want to earn a living to scamming vulnerable patients with so-called “stem cell treatments” have been upset that the U.S. FDA continues to view stem cell-based therapies
Stem cell treatments, drugs, and the key facts you need to know Read More »
About two months about Geron shocked and disappointed the stem cell community by dropping its stem cell program. The move was reportedly made for financial, not scientific reasons. Biotech companies have to be financially sound in order to help stem cell researchers turn science into cures and Geron’s leadership had to do what it thought
What does Geron’s departure mean for ACT? Some perspectives Read More »
I’m a stem cell researcher and I’m very excited about the potential of stem cell therapies, but my excitement is mostly directed to the future. I’m also a cancer survivor and I know what it is like to get a grave diagnosis and how important hope is and sometimes patients and their families need hope
Stem cell treatments: a report from Canada Read More »
A 60 Minutes broadcast shone a light on problems with stem cell tourism. Let’s talk about this and more good news. In a matter of just a few days, we saw three big positive moves against stem cell tourism that will no doubt make a big difference even if there is a long slog ahead
A trifecta of wins against stem cell tourism: 60 Minutes, FDA, and China Read More »
Last night 60 Minutes broadcasted ( you can watch the episode here) a long awaited 2nd segment in their continuing investigation of stem cell fraud. The first segment investigating phony doctors Stowe and Morales led to their ultimate pursuit by the FBI and indictment, aired in a couple years ago. The new episode on stem
Portrait of an alleged stem cell fraud: my thoughts on 60 Minutes episode Read More »